Effect of Hypnosis on Motor Cortex Excitability

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00416247
First received: December 26, 2006
Last updated: August 4, 2010
Last verified: December 2006
  Purpose

This study is intended to investigate neurophysiological mechanisms of hypnosis using transcranial magnetic stimulation (TMS) and assessment of motor cortex excitability in healthy volunteers under hypnosis.


Condition Intervention
Healthy
Behavioral: Hypnosis

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Effect of Hypnosis on Motor Cortex Excitability

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Cortical Excitability [ Time Frame: Before and after intervention ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: December 2006
Study Completion Date: June 2009
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Hypnosis
    Hypnosis
  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: .

  1. Healthy volunteers aged 20 to 45 years.
  2. Hypnotisability above 14 as measured by the Tellegan absorption scale.

Exclusion Criteria:

  1. Psychiatric diagnosis in axis I or axis II;
  2. Documented history of head injury or seizure disorder;
  3. Evidence of a disorder which could affect peripheral and central conduction such as multiple sclerosis, motor neuron disease, carpal tunnel syndrome, cervical spondylosis, diabetic neuropathy.
  4. Any other contraindication to TMS as specified in the safety guidelines for rTMS (Wassermann, 1998) such as cardiac pacemakers or metallic deep brain electrodes.
  5. Chronic pharmacological treatment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00416247

Locations
Israel
Rambam Medical Center
Haifa, Israel, 31096
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: Ehud Klein, MD Rambam Health Care Campus
  More Information

No publications provided

Responsible Party: Ehud Klein, MD, Head Department of Psychiatry, Rambam Medical Center
ClinicalTrials.gov Identifier: NCT00416247     History of Changes
Other Study ID Numbers: rambam2409_CTIL
Study First Received: December 26, 2006
Last Updated: August 4, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Rambam Health Care Campus:
Hypnosis
TMS
Cortical excitability

ClinicalTrials.gov processed this record on August 28, 2014